| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| DCA Accounting | 1,415 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard Ttl Stk Mkt (ST) | 2021-06 | Donated | 2021-08 | Publicly traded | 62,014 | 54,665 | 7,349 | |||
| Vanguard Ttl Intl Stk Adml (LT) | 2019-08 | Donated | 2021-12 | Publicly traded | 60,000 | 49,179 | 10,821 | |||
| Vanguard Ttl Bd Mkt Adml (LT) | 2019-08 | Donated | 2021-04 | Publicly traded | 405,000 | 398,972 | 6,028 | |||
| Vanguard Ttl Stk Mkt (LT) | 2012-07 | Donated | 2021-08 | Publicly traded | 542,657 | 291,075 | 251,582 | |||
| Life Biosciences | 2021-01 | Donated | 2021-12 | Publicly traded | 0 | 25,564 | -25,564 | |||
| Life Biosciences | 2020-01 | Donated | 2021-12 | Publicly traded | 0 | 1,610 | -1,610 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Vanguard Bonds | 2,351,382 | 2,321,925 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Vanguard Mutual Funds | 4,106,958 | 5,924,695 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Life Biosciences LLC (partnership) | 981,646 | 981,646 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Foreign tax paid | 3,767 | 3,767 |